Mark A Goldberg insider trades

Open-market stock purchases and sales by Mark A Goldberg, Director at Intensity Therapeutics, Inc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

DateStockTradeValue
Jul 16, 2026INTS Intensity Therapeutics, IncBought (not open market)—

Companies traded

  • INTS Intensity Therapeutics, Inc: other filings, last Jul 16, 2026
  • PRXL Parexel International Corp: 30 sales, last Sep 29, 2017

Get free alerts when Mark A Goldberg files a new trade →